Analyst firms · UBS · CC
UBS CC price target and rating history
Chemours Company (CC) · Industrials
UBS rates Chemours Company (CC) Neutral with a $18 price target, as of its latest action on Aug 10, 2026. It has published 5 rating actions on CC since January 2022, including 2 upgrades and 2 downgrades. Across 4 firms with a CC price target in the last 12 months, the median target is $15.50. UBS's $18 is 16% above that.
- Current rating
- Neutral
- Price target
- $18
- Median target, all firms
- $15.50
- Actions on CC
- 5
UBS price target on CC
Every UBS rating on CC
- Aug 10, 2026
- Jul 9, 2024
- Mar 5, 2024
- Jan 24, 2023
- Jan 4, 2022
How other firms rate CC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Mizuho | Neutral | $15 | Oct 14, 2026 |
| Barclays | Equal Weight | $16 | Oct 13, 2026 |
| RBC Capital Markets | Sector Perform | $14 | Oct 13, 2026 |
| UBS | Neutral | $18 | Aug 10, 2026 |
Questions about UBS and CC
- What is UBS's price target for CC?
- UBS's latest stated price target for Chemours Company (CC) is $18, from its action on Aug 10, 2026.
- What is UBS's rating on CC?
- UBS rates CC Neutral, a neutral rating, as of Aug 10, 2026.
- When did UBS last change its view on CC?
- On Aug 10, 2026, UBS downgrades to Neutral from Buy, price target $18.
- How does UBS's CC target compare with other analysts?
- Across 4 firms with a CC price target in the last 12 months, the median target is $15.50. UBS's $18 is 16% above that.
More CC rating histories
All UBS ratingsCC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.